Request Demo
Last update 01 Mar 2025
AWT-020
Last update 01 Mar 2025
Overview
Basic Info
Drug Type Fusion protein |
Synonyms AWT 020, AWT020, JS213 |
Target |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with AWT-020NCT06839105
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AWT020 Alone and in Combination With Other Antitumor Therapies in Patients With Advanced Malignancies
NCT06092580
A Phase 1/2, First-in-human, Open-label Study of Single-agent AWT020 in Patients With Progressive Locally Advanced or Metastatic Cancer
CTR20250393
一项评价AWT020单药以及联合其他抗肿瘤治疗在晚期恶性肿瘤患者中的安全性、耐受性、药代动力学和初步疗效的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of AWT020 alone and in combination with other anti-cancer therapies in patients with advanced malignant tumors
100 Clinical Results associated with AWT-020
Login to view more data
100 Translational Medicine associated with AWT-020
Login to view more data
100 Patents (Medical) associated with AWT-020
Login to view more data
100 Deals associated with AWT-020
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 1 | CN | 14 Feb 2025 | |
| Mucosal Melanoma | Phase 1 | CN | 14 Feb 2025 | |
| Unresectable Melanoma | Phase 1 | CN | 14 Feb 2025 | |
| Unresectable Renal Cell Carcinoma | Phase 1 | CN | 14 Feb 2025 | |
| Non-Small Cell Lung Cancer | Phase 1 | CN | 14 Feb 2025 | |
| Advanced cancer | Phase 1 | CN | 11 Feb 2025 | |
| Melanoma | Phase 1 | AU | - | |
| Renal Cell Carcinoma | Phase 1 | AU | - | |
| Transitional Cell Carcinoma | Phase 1 | AU | - | |
| Advanced Malignant Solid Neoplasm | IND Approval | CN | 05 Feb 2025 |
Login to view more data
Clinical Result
Clinical Result
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free